EXPERT NETWORK ACCESS (INTERVIEWS, SURVEYS)
Clinician research panels
and expert interviews on demand.
Recruiting clinicians for research is slow, and the people who respond to panel invitations are not always the people you need.
Medcase gives you direct access to practicing clinicians — matched by specialty, sub-specialty, geography, language and role — without building a recruitment operation of your own. 140+ countries, 55+ languages.
20K+
Healthcare professionals
in network
140+
Countries
represented
100+
Specialties
200+ sub-specialties
55+
Languages
supported
THE SECOND NUMBER IS THE ONE THAT MATTERS
Our network is 20,000+ licensed clinicians across 100+ specialties and 200+ sub-specialties, and the value is in the second number, not the first.
Cohorts are defined by the variables that actually change the answer: specialty and sub-specialty, provider role, years in practice, country, language, care setting, and current clinical context. If seniority or geography is likely to split the response, the cohort can be designed to test that rather than average it away.
Not gig work. Not a panel of respondents. Professional contribution by licensed clinicians, compensated at professional rates.
Why matching beats volume.
A panel of 500 general physicians will tell you less about pediatric oncology practice than eleven pediatric oncologists.
WHAT THE NETWORK IS USED FOR
QUALITATIVE INTERVIEWS
WORKFLOW · UNMET NEED
Depth interviews with clinicians currently practicing in the field you are asking about. The common thread across every engagement: you need the view of someone currently practicing, in a specific field, often in a specific market.
↓ What you get back
Structured output with the reviewer profile documented alongside it — not just the findings, but who produced them.
QUANTITATIVE SURVEYS
DEFINED SPECIALTY COHORTS
Surveys fielded across a cohort specified by role, seniority, market and care setting — and enough of them that you can be confident the view is representative. Fielded in 55+ languages.
↓ What you get back
Quality-reviewed responses, with incomplete or inconsistent data followed up rather than dropped.
ADVISORY, PROTOCOL & KOL
PANELS · FEASIBILITY · KOL
Advisory panels convened around a product or study question, clinical feasibility and protocol review before a trial commits to a design, and KOL identification within a therapeutic area.
↓ What you get back
For research feeding a regulatory, investment or clinical decision, being able to show who answered is part of the deliverable.
ONE COHORT DESIGN, ONE TEAM, ONE SET OF OUTPUTS
Multi-market research
without multi-market vendors.
COHORT VARIABLES
Where seniority or geography is likely to split the response, the cohort is designed to test that rather than average it away.
The network spans 140+ countries and 55+ languages, with 10,000+ clinicians in the US. For research that crosses markets, that removes the usual overhead of appointing a separate recruiter per country and reconciling incompatible methodologies afterwards.
Language matters beyond translation. Terminology, care pathways, drug availability and referral norms differ by market — a question that works in the US may not be answerable as written in Brazil or Germany. We flag that at design stage rather than discovering it in the data.
How an engagement runs.
02
Specify the clinician profile — specialty, role, geography, language, experience.
04
Run the interviews, survey or panel to the agreed protocol.
06
Deliver structured output with the reviewer profile documented alongside it.
01
Define the research question
and what decision it informs.
03
Recruit and screen
against those criteria.
05
Quality-review responses and follow up on incomplete or inconsistent data.
You receive the composition of the cohort that produced the findings, not just the findings.
Compliance and
clinician relationships
HIPAA-compliant workflows & ISO 27001
Engagements run under HIPAA-compliant workflows with ISO 27001 information-security controls. Clinicians in the network are licensed and credentialed, engaged and compensated directly by Medcase at professional rates, and briefed on the purpose and scope of each engagement before participating.
Frequently asked questions
It depends on how narrow the profile is. A broad primary-care cohort moves faster than eleven interventional neuroradiologists in three specific markets. We give a realistic timeline at scoping rather than a standard one.
Often, across 140+ countries. Feasibility for a specific profile is confirmed before a project is committed.
Yes. One cohort design, one operating team, one set of outputs — that is one of the main reasons teams use the network rather than a local recruiter.
We can help shape the cohort and screening criteria. The research question and methodology stay with you, or with your agency.
Usually, subject to availability and any independence requirements the study imposes.
Every clinician in the network is licensed and credentialed before participating. 100% licensed and credentialed, no crowdsourcing.
Yes, across 55+ languages. We also flag at design stage where a question will not translate into a given market's care pathway.
AI, MedTech and pharma teams, and the research agencies working on their behalf.
Ship when clinicians sign off,
not when the demo goes well.
Tell us what you're building — we'll tell you exactly how we can help. Send the research question, the clinician profile and the markets involved, and we'll come back on feasibility, timeline and cohort design.
Get a Quote
Other
services
Managed end to end — recruitment, credentialing, onboarding, training, scheduling, payments and QA. One accountable team.
Medical data annotation & labeling
Specialty-matched annotation of medical imaging, clinical text, EHR, video, waveform and audio data for AI training. Every label is placed by a licensed HCP matched to the data.
Clinical AI product validation & testing
Structured, multi-country testing of clinical AI tools by active licensed healthcare professionals: reader studies, model validation, benchmark review, LLM and multimodal evaluation. Built for FDA and EU AI Act requirements.